Quent Capital, LLC

Position in INCY — Incyte Corp

CIK 1912338 NEW YORK, NY

Position in INCY

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$48,631

+$11,360 QoQ

Shares Held

429

+8.3% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#702

of 854 holders

Holding Since

Mar 2022

17 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Quent Capital, LLC holds $1,397,990 across 37 Biotechnology names. INCY ranks #7 (3.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	462	$229,489
2	IMMX	Immix Biopharma, Inc.	20,000	$206,200
3	REGN	Regeneron Pharmaceuticals, Inc.	312	$194,544
4	MRVI	Maravai Lifesciences Holdings, Inc.	30,000	$187,200
5	SLS	SELLAS Life Sciences Group, Inc.	7,022	$103,644
6	JAZZ	Jazz Pharmaceuticals plc	308	$74,218
7	INCY	Incyte Corp This page	429	$48,631
8	PTGX	Protagonist Therapeutics, Inc	337	$41,309

17 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$48,631	429	+8.3%	Shares	Sole	2026-08-07
2026-03-31	$37,271	396	+7.9%	Shares	Sole	2026-04-28
2025-12-31	$36,248	367	+3.7%	Shares	Sole	2026-01-29
2025-09-30	$30,022	354	+205.2%	Shares	Sole	2025-10-27
2025-03-31	$7,023	116	+36.5%	Shares	Sole	2025-04-04
2024-12-31	$5,870	85	+4.9%	Shares	Sole	2025-01-29
2024-09-30	$5,354	81	+12.5%	Shares	Sole	2024-10-04
2024-06-30	$4,364	72	+84.6%	Shares	Sole	2024-07-08
2024-03-31	$2,221	39	-29.1%	Shares	Sole	2024-06-28
2023-12-31	$3,453	55	+400.0%	Shares	Sole	2024-06-17
2023-09-30	$635	11	0.0%	Shares	Sole	2024-06-17
2023-06-30	$684	11	-71.8%	Shares	Sole	2024-06-17
2023-03-31	$2,818	39	0.0%	Shares	Sole	2024-06-17
2022-12-31	$3,132	39	0.0%	Shares	Sole	2023-01-19
2022-09-30	$2,598	39	0.0%	Shares	Sole	2022-11-10
2022-06-30	$2,962	39	+18.2%	Shares	Sole	2022-08-08
2022-03-31	$2,620	33	—	Shares	Sole	2022-05-12
No filing history on record for this holder in this stock.